Article
Drug-resistant variants of Escherichia coli thymidylate synthase: effects of substitutions at Pro-254.
Molecular pharmacology - 1 Feb 2000
Fantz C, Shaw D, Jennings W, Forsthoefel A, Kitchens M, Phan J, Minor W, Lebioda L, Berger F G, Spencer H T
Abstract excerpt
Drug-resistant variants of thymidylate synthase (TS) can potentially be used in gene therapy applications to decrease the myelosuppressive side effects of TS-directed anticancer agents or to select genetically modified cells in vivo. Mutations of proline 303 of human TS confer resistance to TS-directed fluoropyrimidines and antifolates (). We generated the corresponding variants in Escherichia coli TS (ecTS),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
